Download Full Text (474 KB)
Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement in Treatment of Aortic Valve Stenosis
Faculty Mentor: Lorie Zelna, M.S., R.T. (R)(MR)
The purpose of this project is to explore the benefits and risks of the transcatheter aortic valve replacement (TAVR) procedure compared to the surgical aortic valve replacement (SAVR) procedure in the treatment of aortic valve stenosis (AS). TAVR is a lifesaving procedure for patients who are unable to undergo the surgery to fix their aortic valve stenosis. Aortic valve stenosis is a narrowing of the aortic valve of the heart that causes the valve to not open fully. When the aortic valve does not open fully this causes a reduction or blocking of blood flow from the heart into the aorta. The equipment and technology used for TAVR procedures is becoming more advanced and safer to ensure postoperative outcomes are positive and recovery is quick. This project focuses on a male, 78-year-old, patient that underwent a TAVR procedure on October 14, 2021. The patient was diagnosed with severe aortic valve stenosis and had a TAVR procedure done previously in May of 2019. There was a history of cancer, obesity, kidney failure, and being a former smoker. Initial visit to the hospital’s emergency room was chest pain and a syncope episode. Without another TAVR procedure the patient had a 50% chance of mortality in 6-12 months. Keywords: aortic valve stenosis (AS), transcatheter aortic valve replacement (TAVR), surgical aortic valve replacement (SAVR)
aortic valve stenosis (AS), transcatheter aortic valve replacement (TAVR), surgical aortic valve replacement (SAVR)
Medicine and Health Sciences
Blannett, Ashlee, "Transcatheter Aortic Valve Replacement (TAVR)" (2021). Medical Imaging Senior Posters. 19.